Rohini K. Coorg, MD


Less Invasive Epilepsy Surgery May Help Turn Candidates Into Consults

Recent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.

Sait Ashina, MD


Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS

The assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]

Erika Fullwood Augustine, MD, MS


Evolving Landscape of Pediatric Neurology: Erika Fullwood Augustine, MD, MS

The associate chief science officer at Kennedy Krieger Institute shared thoughts on the state of pediatric neurology and the significance of being named winner of the Sydney Carter Award. [WATCH TIME: 3 minutes]

Deborah Miller, PhD


Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhD

The staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]

Matthew Shepard, MD


Exploring Potential Therapeutic Opportunities for GammaTile in Neurosurgery: Matthew Shepard, MD

The neurosurgeon at Allegheny Health Network discussed the current uses of GammaTile following tumor removal, and the research needed to unlock greater potential. [WATCH TIME: 3 minutes]

Farrah Mateen, MD, PhD


Creating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhD

The associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital discussed the ways employers and clinicians can alleviate work hardships experienced by patients with NMOSD. [WATCH TIME: 3 minutes]

David Fischer, MD


Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD

The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]

Douglas Scharre, MD


Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD

Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]

Mitzi Joi Williams, MD


Pros and Cons of Telemedicine for Multiple Sclerosis: Mitzi Joi Williams, MD

The founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her reasoning as to why she hopes telemedicine is here to stay. [WATCH TIME: 4 minutes]

Carl Gold, MD, MS


AUPN Leadership Minute Episode 35: Building a High-Quality QI Program

Episode 35 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Carl Gold, MD, MS, of Stanford University. [WATCH TIME: 5 minutes]

Debra Davis, CRNP


Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.

Indu Subramanian, MD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Michael Levy, MD, PhD


Subgroup Analyses of Ravulizumab Demonstrates Effectiveness Across Patient Populations: Michael Levy, MD, PhD

The associate professor of neurology at Harvard Medical School talked about the subgroup analysis on ravulizumab in NMOSD that was presented at the 2023 AAN Annual Meeting. [WATCH TIME: 5 minutes]

Deepti Zutshi, MD, FAAN


Expensive Antiseizure Medications Cause for Concern for Patients with Epilepsy: Deepti Zutshi, MD, FAAN

The associate professor of neurology at Wayne State University in Detroit, Michigan, spoke about expensive antiseizure medications for epilepsy along with spending for Medicare and Medicaid at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]

Clifton L. Gooch, MD


Ethical Values and Principals in Neurology Departments, Medical School

A group of esteemed panelists discussed the important values neurology department directors and educators should prioritize when teaching students of the future. [WATCH TIME: 6 minutes]

Marcia Morita-Sherman, MD, PhD


Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?

Thomas Topley, MBA


The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley

The executive director of the Bensalem Rescue Squad spoke specifically to how the MSU has shifted the paradigm of care that EMS can provide to individuals in the community. [WATCH TIME: 4 minutes]

Glenn Graham, MD, PhD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Michael Weiner, MD


Advancements in the Alzheimer Disease Field: Michael Weiner, MD

The director of the Brain Health Registry discussed advancements in AD, following the publication of a systematic review on the predictors of Aß.

Lawrence Elmer, MD, PhD


Remaining Questions and Next Steps for Parkinson Agent P2B001: Lawrence Elmer, MD, PhD; Cheryl Fitzer-Attas, PhD

The medical director of the Center for Neurological Disorders at the University of Toledo discussed positive phase 3 findings assessing P2B001, and how the agent would potentially fit in the Parkinson treatment landscape. [WATCH TIME: 4 minutes]

Rachelle S. Doody, MD, PhD


Roche’s NeuroToolKit in Alzheimer Disease Research: Rachelle S. Doody, MD, PhD

The global head of Neurodegeneration at Roche/Genentech shared insight into the development of the company’s NeuroToolKit and its use in its Alzheimer disease research.

Bryan Walker, MHS, PA-C


Managing MS in the Community: Advice and Resources

Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).

Russell Cerejo, MD


Rehab Process and Need for Improved Guidelines of Basilar Artery Occlusions: Russell Cerejo, MD

The vascular neurologist at Allegheny Health Network provided insight on the need to create consensus guidelines that further explain the treatment, management, and rehab of basilar artery occlusions. [WATCH TIME: 3 minutes]

Salima Brillman, MD


A Multifaceted Approach to Understanding ON and OFF Periods in Parkinson Disease: Salima Brillman, MD

At AMTRD 2023, the movement disorder neurologist at the Parkinson’s Disease and Movement Disorder Center of Silicon Valley talked about the current care landscape for Parkinson disease and improving on-time for patients experiencing OFF periods. [WATCH TIME: 5 minutes]

Richard C. Burgess, MD, PhD


The Current State and Future Promise of Magnetoencephalography (MEG) in Epilepsy and Beyond

Magnetoencephalography provides an opportunity for physicians to capture a more dynamic view of brain function over time and space that may offer an advantage to clinical care.

Dilesh Doshi, PharmD


Reassessing Treatment Options, Quetiapine for Parkinson Disease Psychosis: Dilesh Doshi, PharmD

The vice president of Health Economic and Outcomes Research at Acadia Pharmaceuticals provided perspective on the negative effects seen from quetiapine and how the knowledge of pimavanserin has improved since approval. [WATCH TIME: 5 minutes]

Ludwig A. Kappos, MD


Predicting Patient Response to MS Treatment Using Cognitive Outcome Measures: Ludwig Kappos, MD, FEAN, FAAN

The professor of neurology at the University of Basel provided insight on a new methodology that allows depiction of patient profiles from baseline characteristics and their associations with individual outcomes. [WATCH NOW: 5 minutes]

Vijayshree Yadav, MD, MCR, FANA, FAAN


Investigating the Impact of a Low-Fat Diet on Quality of Life and Symptom Management in MS: Vijayshree Yadav, MD, MCR, FANA, FAAN

The professor of neurology at Oregon Health & Science University talked about a study on a modified low-fat diet intervention and its effects on fatigue in patients with multiple sclerosis over a 16-week period at CMSC 2023. [WATCH TIME: 8 minutes]

Richard Bogan, MD, FCCP, FAASM


Improving Awareness of Sleep-Heart Associations and the Precursor Signs to Heart Issues: Richard Bogan, MD, FCCP, FAASM

The medical director of SleepMed in South Carolina discussed the need for more overall awareness of poor sleep and the risk factors associated with worsened heart health. [WATCH TIME: 3 minutes]

Mazen Elkurd, DO


Seeking Clarity in Patient Stratification of Parkinson Disease: Mazen Elkurd, DO

The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, talked about the dilemma of stratifying patients with Parkinson disease based on various criteria and emphasized the need for a consensus on classification. [WATCH TIME: 3 minutes]

© 2023 MJH Life Sciences

All rights reserved.